Skip to content

Vitamin D Status and Dose Response in Infants

Vitamin D Status and Dose Response in Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01042561
Enrollment
64
Registered
2010-01-05
Start date
2009-08-07
Completion date
2010-08-01
Last updated
2023-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D, Prematurity

Keywords

vitamin d, prematurity, 25(OH)D, infant, CRP, PTH

Brief summary

This study will examine the relationship of serum 25(OH)D levels in infants 32 weeks and greater gestation who are fed infant formula to markers of inflammation and bone metabolism.

Detailed description

It is hypothesized that serum 25(OH)D levels in infants 32 weeks and greater gestation are not maintained at optimal levels of greater than 32 ng/Ml with currently available infant formulas, and that this will have an inverse relationship with markers of inflammation and bone metabolism.

Interventions

DIETARY_SUPPLEMENTVitamin D3

400 IU of vitamin D3 daily. Pts will recieve 1 mL a day with a feeding for 28 days.

DIETARY_SUPPLEMENTvitamin D3 placebo

Placebo designed by research pharmacist. Pts will recieve 1 mL a day with feedings for 28 days.

Sponsors

Creighton University Medical Center
CollaboratorOTHER
University of Nebraska
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
5 Minutes to 3 Months
Healthy volunteers
Yes

Inclusion criteria

* greater than 32 weeks gestation, * exclusively formula fed.

Exclusion criteria

* less than 32 weeks gestation, * less than 1500 grams, * recieving maternal breast milk, * recieving parenteral nutrition, * congenital anomolies, * disorders of vitamin D metabolism, * inborn errors of metabolism, * seizure disorders, * parathroid disease, * liver, GI tract, or kidney disease, and * disorders of calcium metabolism.

Design outcomes

Primary

MeasureTime frameDescription
Serum 25-Hydroxyvitamin D [25(OH)D] Levels30 daysTotal serum 25(OH)D level is currently considered the best indicator of vitamin D supply to the body from cutaneous synthesis and nutritional intake. For infants, ≤37.5 nmol/L (15 ng/mL) would be considered indicative of deficiency and \>50 nmol/L (20 ng/mL) as indicative of vitamin D sufficiency.

Secondary

MeasureTime frameDescription
Serum C-reactive protein (CRP)30 daysSerum C-reactive protein (CRP) is a protein made by the liver and increases when there's inflammation in the body. The upper normal reference levels range from 6 to 20 mg/L as cutoff levels to indicate the presence of sepsis or infection.
Serum intact parathyroid hormone (iPTH)30 daysSecretion of parathyroid hormone (PTH) is regulated by the level of calcium in the blood. Low serum calcium causes increased PTH to be secreted, whereas increased serum calcium inhibits PTH release. Normal values are 10 to 55 picograms per milliliter (pg/mL).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026